Control of COVID-19 Outbreaks in Long Term Care

Stopped Recruitment challenges

Conditions

• COVID-19
• SARS-CoV-2

Interventions

• DRUG: Favipiravir
• DRUG: Favipiravir Placebo

Sponsor

Appili Therapeutics Inc.

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]